11.5 Product Indications, Contraindications, and Selection

Product Selection by Indication and Safety

The WCC exam does not require memorizing manufacturer catalogs; it requires knowing why a category is selected and when it is a poor fit. Product choice follows assessment: etiology, tissue type, drainage amount, infection signs, periwound condition, pain, allergies, wear time, setting, cost awareness, and patient/caregiver ability. The blueprint places indications and contraindications squarely in Risk and Prevention, so safety is central.

The guiding principle of moist wound healing is to keep the wound bed moist but the periwound dry. Translate that into a moisture-balance decision: donate moisture to dry wounds (if perfusion and etiology allow) and absorb moisture from heavily draining wounds while protecting the periwound. No dressing compensates for unrelieved pressure, uncontrolled edema, ischemia, or unmanaged diabetes.

Category Map for Exam Reasoning

Worked Scenarios

A venous-type leg ulcer with moderate drainage and a macerated periwound calls for exudate control (alginate or foam), periwound barrier film, an edema/compression plan only when arterial disease is excluded and compression is ordered, and reassessment of wear time. Add absent pulses or ischemic rest pain to the same stem and the answer shifts to vascular evaluation before compression.

A dry, stable eschar on an ischemic limb is a classic contraindication item: do not apply a moisture-donating hydrogel to soften it, because autolytic debridement of a poorly perfused, noninfected eschar can convert a stable wound into an open, infected one. Keep it dry and refer for perfusion assessment.

Reading Contraindication Clues

Contraindications hide in one or two words: adhesive allergy, fragile/skin-tear-prone skin, heavy drainage, undermining or tunneling, dry eschar on an ischemic limb, exposed bone/tendon, infection signs, or uncontrolled pain can make a familiar product unsafe or incomplete. Slow down when the stem includes perfusion, infection, or scope clues. If the product requires a skill or order outside the WCC role, the correct action is collaboration or referral.

Common Traps and the Administration Angle

• Do not pick a product because it sounds advanced; a costly antimicrobial is wrong if the wound simply needs offloading and moisture balance.
• Conversely, a plain dressing is inadequate when the stem shows spreading erythema, fever, or malodor with systemic signs.
• Real selection respects formularies, payer rules, and home feasibility (hand function, vision, supplies, caregiver support). Prevention fails when a technically correct product is impossible to use. Close the loop by reassessing wound size, tissue, drainage, odor, periwound, pain, and adherence; if the wound stalls, re-examine etiology rather than stacking products.

Matching Absorbency to Drainage Level

A reliable way to answer selection items is to grade exudate and then pick a category with the matching capacity. None to minimal drainage with a dry bed favors a moisture donor (hydrogel) or a simple film. Light drainage suits a hydrocolloid or thin foam. Moderate drainage suits foam. Heavy drainage suits an alginate or gelling-fiber dressing, often with a secondary absorptive cover and a longer reach toward containment for very high output. A mismatch is the classic wrong answer: an alginate on a dry wound desiccates the bed, while a film over a heavily draining wound leaks, macerates, and lifts.

Always re-grade drainage at each change because exudate falls as a wound improves, and the dressing should de-escalate with it.

Adjunctive and Advanced Therapies

The exam may mention negative pressure wound therapy (NPWT), used to manage exudate and promote granulation in selected deep or heavily draining wounds, but contraindicated over untreated osteomyelitis, malignancy in the wound, exposed unprotected vessels or organs, and necrotic tissue with eschar. Collagen, growth-factor, and cellular/tissue-based products are reserved for clean, adequately perfused, non-healing wounds after standard care has been optimized, not as first-line prevention. Compression is therapy for venous disease only after arterial insufficiency is excluded.

The recurring lesson is that advanced therapy never substitutes for fixing the underlying cause and confirming perfusion.

Allergy, Cost, and Documentation

Screen for adhesive, latex, silver, and iodine sensitivities before selecting a product, and substitute within the same functional category when an allergy is present. Cost and formulary realities matter, but they break ties between equally appropriate products; they never justify an unsafe or mismatched choice. Document the etiology, the wound and periwound assessment, the product category and rationale, contraindications considered, patient tolerance and teaching, and the reassessment date so the selection survives audit and handoff.